Since BACE-1 is required to cleave APP into Aβ peptides [141,142], the astrocyte-derived exosomes that carry BACE-1 represent critical tools for testing the AD therapies that inhibit BACE-1 [137]. Here, APP is linked to Alzheimer disease.